Skip to content
Recall Observatory FDA recall evidence

Device product

VersaCross RF Wire (VXW). Indicated for creation of an atrial septal defect in the heart. Product ID VXW0002 Device approved and commercialized in Japan only.

Z-2104-2025

June 10, 2025

Class II

Product summary

Firm
Boston Scientific Corporation
Event
Event 97036
Status
Ongoing
Classification
Class II
Quantity
14,724
Official record key
device-enforcement:Z-2104-2025

Official wording

Reason: Potential for hole in the Tyvek layer of the sterile barrier pouch, which may compromise device sterility. Issue could potentially lead to systemic infection and sepsis in worst case scenario. Potential punctures may go undetected in clinical settings due to small size and variable location.

Code information: UDI-DI 00685447006121 Lot 35935598

Distribution pattern: Worldwide distribution - US Nationwide and the countries of Canada, Hong Kong, and Japan.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Potential for hole in the Tyvek layer of the sterile barrier pouch, which may compromise device sterility. Issue could potentially lead to systemic infection and sepsis in worst case scenario. Potential punctures may go undetected in clinical settings due to small size and variable location.